jo8b02750_si_001.pdf (1.52 MB)
Download file

Development of a Convergent Large-Scale Synthesis for Venetoclax, a First-in-Class BCL‑2 Selective Inhibitor

Download (1.52 MB)
journal contribution
posted on 07.01.2019, 00:00 by Yi-Yin Ku, Vincent S. Chan, Alan Christesen, Timothy Grieme, Mathew Mulhern, Yu-Ming Pu, Michael D. Wendt
The process development of a new synthetic route leading to an efficient and robust synthetic process for venetoclax (1: the active pharmaceutical ingredient (API) in Venclexta) is described. The redesigned synthesis features a Buchwald-Hartwig amination to construct the core ester 23c in a convergent fashion by connecting two key building blocks (4c and 26), which is then followed by a uniquely effective saponification reaction of 23c using anhydrous hydroxide generated in situ to obtain 2. Finally, the coupling of the penultimate core acid 2 with sulfonamide 3 furnishes drug substance 1 with consistently high quality. The challenges and solutions for the key Pd-catalyzed C–N cross-coupling will also be discussed in detail. The improved synthesis overcomes many of the initial scale-up challenges and was accomplished in 46% overall yield from 3,3-dimethyldicyclohexanone (6), more than doubling the overall yield of the first generation route. The new process was successfully implemented for producing large quantities of 1 with >99% area purity.

History